Karriere machen bei Ultragenyx

Stellenangebote bei Ultragenyx

Medical Affairs Manager

POSITION: Medical Affairs Manager Germany / Central Europe
RANK: tbd
DATE:  28 November 2018
REPORTS TO: General Manager, Germany / Central Europe
DEPARTMENT: Medical Affairs Europe


The Medical Affairs Manager is a newly created key function on the Ultragenyx team for Germany and neighbouring countries in Central Europe with paramount input into the future development of the local organization. The central responsibility of the incumbent is to develop and execute a local medical strategy with the purpose of supporting HCPs in delivering the best patient care in the therapeutic areas that Ultragenyx addresses by driving key scientific initiatives to improve the diagnostic and therapeutic standard of care in the best interest of affected patients and families. This includes education and dissemination of medical knowledge in highly specialized fields but also devising strategies that help the identification of patients as well as facilitating their access to treatment.


  • Determine local Medical Affairs strategy in alignment with European Medical Team and plan resource allocation
  • Provide scientific contribution into regional market access processes, including reimbursement dossier review, value communication to stakeholders and management of relations with professional societies, the local patient advocacy community and policy makers
  • Analyze local environment to identify and prioritize KOLs and referral patterns as well as gaps in infrastructure for patient care and develop strategies to address the unmet medical need in patient diagnosis and care provision
  • Support local scientific community in the dissemination of medical education, foster cross-functional networking, address and internally process requests for investigator-sponsored research and unsolicited compassionate use inquiries
  • Develop strategic initiatives with the purpose of shaping policy making to the benefit of patient care. Provide operational oversight and coordinate execution of alliances with external partners (e.g. newborn screening)
  • Provide support and act as main local contact for specific and umbrella patient advocacy organizations
  • In cooperation with global Clinical Operations, identify potential local investigators, provide input into trial design from a local perspective. Support local execution and facilitate reporting of Disease Monitoring programs and clinical trials
  • Interact with global Medical teams to contribute to international projects and guide their local execution, provide input on local data needs, especially in context of AMNOG and other reimbursement process
  • Review disease education and promotion material and execute function of Information Officer according to German Pharmaceuticals Act §74
  • Responsibility for local Medical Affairs budget drafting and monitoring
  • Foster international collaboration of scientific community, organize participation in national scientific conventions and preceptorship programs
  • Generate training material and help in the on-boarding and training of new colleagues
  • Assist in the evaluation of new business opportunities by evaluating the treatment landscape and unmet medical need in the territory
  • Address unsolicited requests for compassionate use from HCPs and internally process applications for grants

Key internal contacts
Local General Management / Market Access, European Medical Affairs Team, Global Medical Affairs Team, Drug Safety, Regulatory, Quality, Legal/Compliance, Finance, Clinical Operations

Key external contacts
KOLs, Scientific associations, patient advocacy groups, service providers (e.g. medical writers, medical education agencies, online platforms, translation agencies)



  • Physician, Pharmacist or scientist with a university education in a relevant scientific field, B.Sc. minimal requirement
  • Fluent written and spoken German and English mandatory. Knowledge of an Eastern European language is an asset


  • Minimum of 7 years of experience in pharmaceutical industry
  • Experience in Orphan Drugs or highly specialized medical areas imperative – knowledge of at least 3 different medical specialties and established relationships to KOLs desirable. As a minimum, 3 years of KOL management on a national level required
  • Launch experience required, direct involvement in AMNOG processes strongly preferred
  • Outstanding insights into German health care system and the interactions and interdependencies of sick funds, KVs, MDK, IQWiG, GKV-SV and GBA with HCPs
  • Thorough knowledge of local relevant laws and Pharmaceutical industry’s code of conduct, impeccable business integrity record
  • Understanding of GCP and GDP standards


  • High level of energy, ambition and intellectual curiosity with the ability to rapidly digest and interpret new information
  • Excellent communication skills in personal and remote (phone and online) interactions
  • Discipline and self-motivation, ability to work autonomously and deliver against defined timelines
  • Creativity and open-mindedness to pursue challenging objectives with little investment
  • Resilience and organizational skills that allow completion of multiple competing tasks under stress
  • Capable of working in a complex matrix environment
  • Professional attitude with courtesy, respect and self-confidence and a priority for impeccable business integrity
  • IT skills; competent with Microsoft Outlook, Word, Excel and PowerPoint


Frequent domestic and occasional international travel including overnight stays is required
Valid and clean driver’s licence

Bitte richten Sie Ihre Bewerbung an

Ultragenyx Germany GmbH
Friedrichstr. 191
10117 Berlin

Tel.: +49 30 – 2065 9232

Über Ultragenyx

Ultragenyx ist ein forschendes, börsennotiertes biopharmazeutisches Unternehmen mit Sitz in Novato, Kalifornien (USA), das neuartige Arzneimittel zur Behandlung seltener Erkrankungen entwickelt. Der Schwerpunkt liegt dabei auf schweren, erblich bedingten Erkrankungen. Seit der Gründung im Jahre 2010 hat Ultragenyx ein breites Portfolio verschiedener Substanzen entwickelt mit dem Ziel, damit Krankheiten mit hohem medizinischen Bedarf zu behandeln, für die bisher keine Therapien verfügbar sind.

Derzeit untersucht Ultragenyx 6 Substanzen in klinischen Studien, davon 4 Substanzen in der Phase 3. Weitere 7 Substanzen sind in präklinischer Entwicklung.

Im Herbst 2016 wurde die Ultragenyx Germany GmbH als deutsche Niederlassung mit Sitz in Berlin gegründet.

Weitere Informationen erhalten Sie auch auf der Webseite unserer amerikanischen Muttergesellschaft:


Bitte treffen Sie eine Auswahl. Weitere Informationen zu den Auswirkungen Ihrer Auswahl finden Sie unter Hilfe.

Treffen Sie eine Auswahl um fortzufahren

Ihre Auswahl wurde gespeichert!



Um fortfahren zu können, müssen Sie eine Cookie-Auswahl treffen. Nachfolgend erhalten Sie eine Erläuterung der verschiedenen Optionen und ihrer Bedeutung.

  • Cookies für Tracking durch Google Analytics zulassen:
    Mit dieser Einstellung erlauben Sie uns die Protokollierung Ihres Webseitenbesuches durch Google-Analytics. Ihre IP-Adresse wird dabei anonymisiert, so dass kein Rückschluss auf Ihre Person möglich ist.
  • Nur technisch notwendige Cookies zulassen:
    Es werden keine Cookies gesetzt, es sei denn, es handelt sich um technisch notwendige Cookies. Ihr Webseitenbesuch wird nicht durch Google-Analytics protokolliert.

Sie können Ihre Cookie-Einstellung jederzeit hier ändern: Datenschutz. Impressum